211 related articles for article (PubMed ID: 32523653)
1. Amplifications of stemness genes and the capacity of breast tumors for metastasis.
Litviakov N; Ibragimova M; Tsyganov M; Kazantseva P; Deryusheva I; Pevzner A; Doroshenko A; Garbukov E; Tarabanovskaya N; Slonimskaya E
Oncotarget; 2020 May; 11(21):1988-2001. PubMed ID: 32523653
[TBL] [Abstract][Full Text] [Related]
2. Amplifications of Stemness Gene Loci-New Markers for the Determination of the Need for Neoadjuvant Chemotherapy for Patients with Breast Cancer. A Prospective Study.
Litviakov NV; Ibragimova MK; Tsyganov MM; Kazantseva PV; Doroshenko AV; Garbukov EY; Frolova IG; Slonimskaya EM
J Pers Med; 2021 May; 11(5):. PubMed ID: 34064798
[TBL] [Abstract][Full Text] [Related]
3. Breast tumour cell subpopulations with expression of the MYC and OCT4 proteins.
Litviakov NV; Bychkov VA; Stakheeva MN; Ibragimova MK; Tsyganov MM; Gaptulbarova KA; Tashireva LA; Bondar LN; Garbukov EY; Slonimskaya EM
J Mol Histol; 2020 Dec; 51(6):717-728. PubMed ID: 33037978
[TBL] [Abstract][Full Text] [Related]
4. CD24+CD44+CD54+EpCAM+ gastric cancer stem cells predict tumor progression and metastasis: clinical and experimental evidence.
Gómez-Gallegos AA; Ramírez-Vidal L; Becerril-Rico J; Pérez-Islas E; Hernandez-Peralta ZJ; Toledo-Guzmán ME; García-Carrancá A; Langley E; Hernández-Guerrero A; López-Casillas F; Herrera-Goepfert R; Oñate-Ocaña LF; Ortiz-Sánchez E
Stem Cell Res Ther; 2023 Feb; 14(1):16. PubMed ID: 36737794
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant Chemotherapy Induces the Appearance of New Copy Number Aberrations in Breast Tumor and is Associated with Metastasis.
Litviakov NV; Ibragimova MK; Tsyganov MM; Doroshenko AV; Garbukov EY; Slonimskaya EM
Curr Cancer Drug Targets; 2020; 20(9):681-688. PubMed ID: 31577208
[TBL] [Abstract][Full Text] [Related]
6. TGFβ1 Promotes Breast Cancer Local Invasion and Liver Metastasis by Increasing the CD44
Zhang C; Gao H; Li C; Tu J; Chen Z; Su W; Geng X; Chen X; Wang J; Pan W
Technol Cancer Res Treat; 2018 Jan; 17():1533033818764497. PubMed ID: 29658391
[TBL] [Abstract][Full Text] [Related]
7. Lgr5+CD44+EpCAM+ Strictly Defines Cancer Stem Cells in Human Colorectal Cancer.
Leng Z; Xia Q; Chen J; Li Y; Xu J; Zhao E; Zheng H; Ai W; Dong J
Cell Physiol Biochem; 2018; 46(2):860-872. PubMed ID: 29627827
[TBL] [Abstract][Full Text] [Related]
8. BRD4/nuclear PD-L1/RelB circuit is involved in the stemness of breast cancer cells.
Kim SL; Choi HS; Lee DS
Cell Commun Signal; 2023 Nov; 21(1):315. PubMed ID: 37924094
[TBL] [Abstract][Full Text] [Related]
9. Are CD44
Ryspayeva DE; Smolanka II; Dudnichenko АS; Lyashenko AA; Grinevich YA; Gurianov VG; Koshubarova MV; Seleznev AA
Exp Oncol; 2017 Sep; 39(3):224-228. PubMed ID: 28967636
[TBL] [Abstract][Full Text] [Related]
10. Differences in stemness properties associated with the heterogeneity of luminal-type breast cancer.
Ito T; Sato N; Yamaguchi Y; Tazawa C; Moriya T; Hirakawa H; Hayashi S
Clin Breast Cancer; 2015 Apr; 15(2):e93-103. PubMed ID: 25481840
[TBL] [Abstract][Full Text] [Related]
11. Metalloprotease-disintegrin ADAM12 actively promotes the stem cell-like phenotype in claudin-low breast cancer.
Duhachek-Muggy S; Qi Y; Wise R; Alyahya L; Li H; Hodge J; Zolkiewska A
Mol Cancer; 2017 Feb; 16(1):32. PubMed ID: 28148288
[TBL] [Abstract][Full Text] [Related]
12. p97/VCP is highly expressed in the stem-like cells of breast cancer and controls cancer stemness partly through the unfolded protein response.
Li C; Huang Y; Fan Q; Quan H; Dong Y; Nie M; Wang J; Xie F; Ji J; Zhou L; Zheng Z; Wang L
Cell Death Dis; 2021 Mar; 12(4):286. PubMed ID: 33731668
[TBL] [Abstract][Full Text] [Related]
13. СD44+/CD24- markers of cancer stem cells in patients with breast cancer of different molecular subtypes.
Chekhun SV; Zadvorny TV; Tymovska YO; Anikusko MF; Novak OE; Polishchuk LZ
Exp Oncol; 2015 Mar; 37(1):58-63. PubMed ID: 25804234
[TBL] [Abstract][Full Text] [Related]
14. Genetic profiling of different phenotypic subsets of breast cancer stem cells (BCSCs) in breast cancer patients.
Zekri AN; Bahnassy A; Mourad M; Malash I; Ahmed O; Abdellateif MS
Cancer Cell Int; 2022 Dec; 22(1):423. PubMed ID: 36585652
[TBL] [Abstract][Full Text] [Related]
15. Mammospheres of letrozole-resistant breast cancer cells enhance breast cancer aggressiveness.
Patel JR; Gallegos KM; Walker RR; Davidson AM; Davenport I; Tilghman SL
Oncol Lett; 2021 Aug; 22(2):620. PubMed ID: 34267813
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer stem cells expressing different stem cell markers exhibit distinct biological characteristics.
Shao J; Fan W; Ma B; Wu Y
Mol Med Rep; 2016 Dec; 14(6):4991-4998. PubMed ID: 27840965
[TBL] [Abstract][Full Text] [Related]
17. Identification of a stemness-related gene panel associated with BET inhibition in triple negative breast cancer.
Serrano-Oviedo L; Nuncia-Cantarero M; Morcillo-Garcia S; Nieto-Jimenez C; Burgos M; Corrales-Sanchez V; Perez-Peña J; Győrffy B; Ocaña A; Galán-Moya EM
Cell Oncol (Dordr); 2020 Jun; 43(3):431-444. PubMed ID: 32166583
[TBL] [Abstract][Full Text] [Related]
18. Comparison of mammosphere formation from stem-like cells of normal breast, malignant primary breast tumors, and MCF-7 cell line.
Ambrose JM; Veeraraghavan VP; Vennila R; Rupert S; Sathyanesan J; Meenakshisundaram R; Selvaraj S; Malayaperumal S; Kullappan M; Dorairaj S; Gujarathi JR; Gandhamaneni SH; Surapaneni KM
J Egypt Natl Canc Inst; 2022 Dec; 34(1):51. PubMed ID: 36504339
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the stemness potency of
Yousefnia S; Ghaedi K; Seyed Forootan F; Nasr Esfahani MH
Tumour Biol; 2019 Aug; 41(8):1010428319869101. PubMed ID: 31423948
[TBL] [Abstract][Full Text] [Related]
20. Anti-metastasis activity of curcumin against breast cancer via the inhibition of stem cell-like properties and EMT.
Hu C; Li M; Guo T; Wang S; Huang W; Yang K; Liao Z; Wang J; Zhang F; Wang H
Phytomedicine; 2019 May; 58():152740. PubMed ID: 31005718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
